An anti-cancer derivative of butyric acid (pivalyloxymethyl butyrate) and daunorubicin cooperatively prolong survival of mice inoculated with monocytic leukaemia cells

British Journal of Cancer

Volumn 75, Issue 6, 1997, Pages 850-854

  Kasukabe, T ^a,b   Rephaeli, A ^a   Honma, Y ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b Ansan Inc   (United States)

Author keywords

AN 9; Butyric acid; Daunorubicin; Monocytic leukaemia cells; Survival

Indexed keywords

ANTILEUKEMIC AGENT; ANTIMITOTIC AGENT; ANTINEOPLASTIC AGENT; BUTYRIC ACID; BUTYRIC ACID DERIVATIVE; CYTARABINE; DACTINOMYCIN; DAUNORUBICIN; ETOPOSIDE; FLUOROURACIL; MERCAPTOPURINE; METHOTREXATE; PIVALOYLOXYMETHYL BUTYRATE; PIVALYLOXYMETHYL BUTYRATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL DIFFERENTIATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA; LEUKEMIA CELL; MONOCYTIC LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031046409     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.151     Document Type: Article

References (21)

1. Aviram A, Zimrah Y, Shaklai M, Nudelman A and Rephaeli A (1994) Comparison between the effect of butyric acid and its prodrug pivalyloxymethylbutyrate on histones hyperacetylation in an HL-60 leukemic cell line. Int J Cancer 56: 906-909
2. Berenbaum M C (1989) What is synergy? Pharmacol Rev 41: 93-141
3. Fenaux P, Vanhaesbroucke C, Estienne M H, Homme C P, Pagniez D, Façon T, Mulot F and Bauters F (1990) Acute monocytic leukaemia in adults: treatment and prognosis in 99 cases. Br J Haematol 75:41-18
4. Honma Y, Kasukabe T and Hozumi M ( 1978) Relationship between leukemogenicity and in riro inducibility of normal differentiation in mouse myeloid leukemia cells. JNall Cancer Inst 61: 837-841
5. Honma Y, Fujita Y, Kasukabe T, Hozumi M, Sampi K, Sakurai M, Tsushima S and Nomura H (1983) Induction of differentiation of human acute non-lymphocytic leukemia cells in primary culture by inducers of differentiation of human myeloid leukemia cell line HL-60. Eur J Cancer Clin Oncol 19: 251-261
6. Honma Y, Honma C and Bloch A (1986) Mechanism of interaction between antincoplastic agents and natural differentiation factors in the induction of human leukemiccell maturation. Cancer Res 46:6311-6315
7. Kanatani Y, Kasukabe T, Hozumi M, Motoyoshi K, Nagata N and Honma Y (1993) Genistein exhibits preferential cytotoxicity to a leukemogenic variant but induces differentiation of a non-Ieukemogenic variant of the mouse monocytic leukemia Mm cell line. Leak Res 17: 847-853
8. Kasukabe T, Honma Y and Hozumi M (1984) Selection of mouse macrophage-like sublines that differ in leukemogenic potential and characterization. J Cell Physloim: 105-112
9. Kasukabe T, Honma Y and Hozumi M (1985) Induction of differentiation of cultured mouse monocytic leukemia cells (Mm-A) by inducers different from those of parent myeloblastic leukemia cells (Ml). Jpn J Cancer Res 76: 1056-1063
10. Lee D, Hayes J, Pruss D and Wolffe A (1993) A positive role for histone acetylation in transcription factor access to nucleosomal DXA. Cell 72:73-84
11. Makishima M, Honma Y, Hozumi M, Sampi K, Hattori M and Motoyoshi K (1991) Induction of differentiation of human leukemia cells by inhibitors of myosin light chain kinase. FEES Lett 287: 175-177
12. Miller A A, Kurschel E, Osieka R and Schmidt C (1987) Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur J Cancer din Oncol 23: 1283-1287
13. Novogradsky A, Dvir A, Ravid A, Shkolnik T, Stenzel K H, Rubin A L and Zaizov R (1983) Effect of polar organic compounds on leukemic cells. Cancer 51: 9-14
14. Nudelman A, Ruse M, Aviram A, Rabizadeh E, Shaklai M, Zimrah Y and Rephaeli A (1992) Novel anticancer prodrugs of butyric acid. J Med Client 35: 687-694
15. Okabe J, Honma Y and Hozumi M (1979) Actinomycin D restores in vivo sensitivity to differentiation induction of non-differentiating mouse myeloid leukemia cells. Int J Cancer 24: 87-91
16. Okabe-Kado J, Honma Y, Hayashi M and Hozumi M (1991) Effects of transforming growth factor and activin A on vitamin D3-induced monocytic differentiation of myeloid leukemia cells. Anticancer Res 11: 181-186
17. Prasad K N (1980) Butyric acid: a small fatty acid with diverse biological functions. LifeSciZl: 1351-1358
18. Rabizadeh E, Shaklai M, Nudelman A, Eisenbach L and Rephaeli A (1993) Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug. FEES Lett 328: 225-229
19. Rephaeli A, Nordenberg J, Aviram A, Rabizadeh E, Zimra Y, Nudelman A, Novogrodsky A and Shaklai M (1994) Butyrate-induced differentiation in leukemic myeloid cells: in \-itro and in vivo studies. Int J Oncol 4: 1387-1391
20. Rephaeli A, Rabizadeh E, Aviram A, Shaklai M. Ruse M and Nudelman A (1991) Derivatives of butyric acid as potential anti-neoplastic agents. Int J Cancer 49: 66-72
21. Shaw M T (1978) The distinctive features of acute monocytic leukemia. Am J Hematol 4: 97-103